<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="73772">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01781143</url>
  </required_header>
  <id_info>
    <org_study_id>2011/669</org_study_id>
    <nct_id>NCT01781143</nct_id>
  </id_info>
  <brief_title>Self-operated Endo-vaginal Telemonitoring (SOET), an Economic and Patient-empowered Method for Ovarian Stimulation for In-vitro Fertilization (IVF)</brief_title>
  <acronym>SOET</acronym>
  <official_title>Self-operated Endo-vaginal Telemonitoring (SOET), an Economic and Patient-empowered Method for Ovarian Stimulation for In-vitro Fertilization (IVF).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Ghent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Flanders Care</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Ghent</source>
  <oversight_info>
    <authority>Belgium: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The SOET project introduces a new strategy for routine follow-up of follicle growth during
      the hormonal treatment phase of an in-vitro fertilization (IVF) treatment cycle. After a
      learning instruction and demo, patients should be able to perform most of their vaginal
      echoes at home. The images can be sent to the medical center over the internet. These images
      are analyzed by the expert.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research</study_design>
  <primary_outcome>
    <measure>Higher efficacy by taking an echo at home.</measure>
    <time_frame>Every 2 days, up to a year.</time_frame>
    <safety_issue>No</safety_issue>
    <description>During an IVF treatment, women are asked to perform the echo themselves, at home. This should create higher efficacy: patients are less stressed and can choose the moment of taking the echo themselves. Furthermore, this should result in a more cost effective and time saving way.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>IVF Treatment</condition>
  <arm_group>
    <arm_group_label>Perform echo at home.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A group of women that follows an IVF treatment, will perform their echoes at home, instead of always make an appointment in the clinic.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Perform Echo at home.</intervention_name>
    <description>A group of women that follows an IVF treatment, will perform their echoes at home, instead of always make an appointment in the clinic.</description>
    <arm_group_label>Perform echo at home.</arm_group_label>
    <other_name>A home echo system will be used to perform an echo.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Woman, suffering from subfertility.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Gerris, Ph.D, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ghent University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jan Gerris, Ph.D, M.D.</last_name>
    <email>Jan.Gerris@ugent.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital VUB</name>
      <address>
        <city>Brussels</city>
        <zip>1000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Willem Verpoest, M.D.</last_name>
      <email>Willem.Verpoest@uzvub.be</email>
    </contact>
    <investigator>
      <last_name>Willem Verpoest, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Oost-Limburg</name>
      <address>
        <city>Genk</city>
        <zip>3600</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Willem Ombelet, M.D.</last_name>
      <email>Willem.Ombelet@pandora.be</email>
    </contact>
    <investigator>
      <last_name>Willem Ombelet, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ghent University Hospital</name>
      <address>
        <city>Ghent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Gerris, Ph.D, M.D.</last_name>
      <email>Jan.Gerris@ugent.be</email>
    </contact>
    <investigator>
      <last_name>Jan Gerris, Ph.D., M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Saint-Vincent</name>
      <address>
        <city>Rocourt</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Annick Delvigne, M.D.</last_name>
      <email>Annick.Delvigne@chc.be</email>
    </contact>
    <investigator>
      <last_name>Annick Delvigne, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <link>
    <url>http://www.uzgent.be</url>
  </link>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 29, 2013</lastchanged_date>
  <firstreceived_date>January 21, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Menthol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
